Results 221 to 230 of about 166,918 (340)

Recombinant α1-Microglobulin Is a Potential Kidney Protector in 177Lu-Octreotate Treatment of Neuroendocrine Tumors [PDF]

open access: bronze, 2019
Charlotte Andersson   +5 more
openalex   +1 more source

Comparative Efficacy of Metabolic/Bariatric Surgery Versus GLP‐1 Receptor Agonists: A Network Meta‐Analysis of Randomized Controlled Trials

open access: yesObesity, EarlyView.
ABSTRACT Objective This study compared the efficacy of metabolic/bariatric surgery (MBS) and GLP‐1 receptor agonists (GLP‐1 RAs), including dual GLP‐1/GIP analogues, for weight and metabolic outcomes in adults with obesity. Methods A network meta‐analysis of randomized controlled trials compared MBS or GLP‐1 RAs versus lifestyle intervention in adults ...
Lucas Sabatella   +9 more
wiley   +1 more source

Supplemental Table 1 from Alternative Lengthening of Telomeres in Primary Pancreatic Neuroendocrine Tumors Is Associated with Aggressive Clinical Behavior and Poor Survival

open access: gold, 2023
Joo Young Kim   +13 more
openalex   +1 more source

Blue‐Gray Papules on the Chest and Face

open access: yes
JEADV Clinical Practice, EarlyView.
Sanjana Likki   +5 more
wiley   +1 more source

High Burden of Pancreatic Surgery for Intraductal Papillary Mucinous Neoplasia With Low‐Grade Dysplasia and Benign Cysts: A Systematic Review and Meta‐Analysis

open access: yesUnited European Gastroenterology Journal, EarlyView.
ABSTRACT Background Intraductal papillary mucinous neoplasms with low‐grade dysplasia (IPMNs w/LGD) and benign cysts, including serous cystadenomas (SCAs), are common pancreatic cystic lesions (PCLs) that are better managed conservatively. The burden of patients who undergo surgical resection for these cysts is unknown.
Samuel Tanner   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy